Quem teve Chikungunya e dengue pode ter urticária?

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Quem teve Chikungunya e dengue pode ter urticária?

Clinical Summary and Overview

In the realm of allergic and immune-mediated diseases, the topic Urticaria It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Quem teve Chikungunya e dengue pode ter urticária?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Quem teve Chikungunya e dengue pode ter urticária?

Relação entre Chikungunya, Dengue e o Surgimento de Urticária

Uma dúvida frequente nos consultórios de alergia e imunologia é se pessoas que já tiveram Chikungunya ou Dengue podem desenvolver quadros de urticária. Durante a fase aguda dessas arboviroses, é muito comum que o paciente apresente manifestações cutâneas, como o rash cutâneo ou lesões avermelhadas em alto relevo, que muitas vezes mimetizam um processo alérgico. No entanto, essas manifestações iniciais decorrem diretamente da ação do vírus no organismo, e não de uma alergia propriamente dita.

Contudo, o surgimento de urticárias crônicas ou persistentes mesmo após a cura clínica da Chikungunya ou da Dengue é perfeitamente possível. Isso ocorre porque esses vírus exercem um impacto significativo sobre o sistema imunológico, interferindo diretamente no equilíbrio de suas células e mediadores químicos.

O Impacto das Arboviroses no Sistema Imunológico

A infecção por vírus como os da Dengue e da Chikungunya pode promover uma desregulação no chamado eixo imunológico Th1/Th2. Esse eixo é o principal responsável por manter a homeostase e a estabilidade do sistema de defesa do corpo:

  • Desregulação do eixo Th1/Th2: Quando ocorre um desequilíbrio, há uma modulação na resposta celular que pode favorecer a via Th2, associada a processos de hipersensibilidade.
  • Aumento de anticorpos específicos: Esse desvio imunológico pode estimular a produção de imunoglobulinas E (IgE), anticorpos diretamente relacionados a reações alérgicas e ao surgimento de lesões cutâneas pruriginosas.
  • Influência nas proteínas virais e linfócitos reguladores: Frações proteicas remanescentes dos vírus podem interagir com as células de defesa, incluindo a redução na eficácia dos linfócitos T reguladores, estruturas fundamentais para conter e modular sintomas inflamatórios e alérgicos.

Estudos científicos demonstram que diversas infecções virais e bacterianas possuem o potencial de alterar temporariamente ou prolongar essa resposta imunorreguladora, desencadeando episódios de urticária mesmo após a eliminação do agente infeccioso.

Caso os sintomas de urticária persistam após a recuperação da Dengue ou da Chikungunya, é fundamental buscar a avaliação de um médico especialista. O profissional poderá conduzir uma investigação detalhada do quadro clínico e indicar o tratamento de controle mais adequado para restabelecer o bem-estar e a qualidade de vida do paciente.

Nota importante: Este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e a orientação médica individualizada com um especialista do Projeto Brasil Sem Alergia ou de sua confiança.

Developments in Evidence-Based Medicine: Pathophysiology and Staged Management of Urticaria and Angioedema

In accordance with the international guideline EAACI/GA²LEN/EuroGuiDerm/APAAACI for the management of urticaria and angioedemaDegranulation of cutaneous mast cells with the release of histamine, platelet-activating factor (PAF), and cytokines promotes vasodilation, dermal plasma extravasation (fleeting pruritic papules/hives or submucosal/subcutaneous angioedema), and cell recruitment. To distinguish histaminergic angioedema from bradykinin-mediated angioedema (associated with C1-esterase inhibitor deficiency/dysfunction — C1-INH — or the use of ACE inhibitors), the presence of hives, the response to antihistamines, and the C4 and C1-INH levels are evaluated. First-line pharmacological treatment of chronic urticaria is based on non-sedating second-generation H1 antihistamines in standard doses, which can be increased up to four times the usual dose under medical prescription before the indication of anti-IgE immunobiological therapy.

💎 Diamond Plan — Peaceful skin, free from constant itching and sleepless flare-ups. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Pathophysiology of Urticaria and Angioedema: Safe Diagnosis and Management

Mast Cell Activation, Histamine, and the Bradykinin Pathway

When isolated recurrent angioedema occurs without surrounding pruritic plaques, immunological reasoning must distinguish histaminergic conditions from those mediated by bradykinin—including hereditary or acquired angioedema due to functional or quantitative deficiency of C1-esterase inhibitor (C1-INH) and reactions induced by angiotensin-converting enzyme (ACE) inhibitor antihypertensive drugs. This differentiation is vital because bradykinin-related angioedema does not respond to conventional antihistamines or corticosteroids.

Therapeutic Escalation without Overuse of Corticosteroids

Identifying aggravating cofactors—especially the use of nonsteroidal anti-inflammatory drugs (NSAIDs), acute stress, and physical stimuli—is part of the specialized consultation. Through the allergy test well-indicated and requiring continuous monitoring aimed at stabilizing mast cells and, in patients with atopic respiratory comorbidities, at allergy vaccineComplete control of symptoms is achieved while preserving overall health.

Impact on Quality of Life, Sleep, and Systemic Well-being

Beyond the direct physical manifestations, uncontrolled urticaria-related conditions profoundly interfere with restorative sleep, concentration at school and work, and emotional balance. Chronic stress, through neuroendocrine mediators and epithelial alarmins, feeds back into the immune inflammatory response. Therefore, instituting a comprehensive approach to clinical and environmental rehabilitation restores daily autonomy and overall well-being to the individual.

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

Living hundreds of miles from an allergist or having to interrupt treatment because of the price of vaccines shouldn't be anyone's fate. With the Diamond Plan, o Brasil Sem Alergia leva o mesmo padrão de cuidado de suas clínicas até a sua casa, com consultas por telemedicina e um caminho mais acessível para a imunoterapia. Uma pele em paz, sem coceira constante e sem crises que roubam o sono.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

It is concluded that the efficient management of issues related to Urticaria It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: